Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Research

SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022

Richard A. TeranComments to Author , Alexandra Gagner, Stephanie Gretsch, Jeff Lauritsen, Daniel Galanto, Kelly Walblay, Peter Ruestow, Colin Korban, Massimo Pacilli, David Kern, Stephanie R. Black, and Irina Tabidze
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.A. Teran); Chicago Department of Public Health, Chicago, Illinois, USA (R.A. Teran, A. Gagner, S. Gretsch, J. Lauritsen, D. Galanto, K. Walblay, P. Ruestow, C. Korban, M. Pacilli, D. Kern, S.R. Black, I. Tabidze)

Main Article

Figure 1

Cumulative incidence (cases/1,000 person-years) of SARS-CoV-2 reinfection by HIV status, Chicago, Illinois, USA, January 1, 2020–May 31, 2022. PWH, persons with HIV; PWOH, persons without HIV.

Figure 1. Cumulative incidence (cases/1,000 person-years) of SARS-CoV-2 reinfection by HIV status, Chicago, Illinois, USA, January 1, 2020–May 31, 2022. PWH, persons with HIV; PWOH, persons without HIV.

Main Article

Page created: September 06, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external